Adapalene
CAS No. 106685-40-9
Adapalene( CD 271 )
Catalog No. M10286 CAS No. 106685-40-9
Adapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 37 | In Stock |
|
| 100MG | 60 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 120 | In Stock |
|
| 1G | 179 | In Stock |
|
Biological Information
-
Product NameAdapalene
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions.
-
DescriptionAdapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions. It is currently marketed by Galderma under the trade names Differin in some countries, and Adaferin in India. (In Vitro):Adapalene (1-200 μM; 24 h) inhibits the viability of ES-2, HOV-7, MCF-7 , Hela, SW1990, HT1080, and MM-468 cells, with IC50s of 10.36 μM, 10.81 μM, 12.00 μM, 19.08 μM, 19.52 μM, 21.70 μM, and 31.47 μM, respectively.Adapalene (10-40 μM; 24 h) induces ES-2 cells apoptosis and inhibits proliferation in vitro.Adapalene (3-30 μM; 6-24 h) significantly increases the G1-phase population in LoVo or DLD1 cells.Adapalene (1-200 μM) inhibits GOT1 activity, with an IC50 of 21.79 μM.Adapalene (10-6-10-3 nM) inhibits the expression of plasma membrane-associated enzyme transglutaminase Type I, with an IC50 of 2.5 nM.(In Vivo):Adapalene (15-100 mg/kg; p.o. daily for 21 days) inhibits the growth of DLD1 cell-derived xenograft tumors in BALB/C nude mice.
-
In Vitro——
-
In VivoAnimal Model:Female BALB/C nude mice (15 g, 4-5 weeks) were injected with DLD1 cells Dosage:15, 20, 65, 100 mg/kg Administration:P.o. daily for 21 days Result:Significantly reduced tumor weight and volume.
-
SynonymsCD 271
-
PathwayMetabolic Enzyme/Protease
-
TargetRetinoid Receptor
-
RecptorRAR| RXR
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number106685-40-9
-
Formula Weight412.52
-
Molecular FormulaC28H28O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 8 mg/mL (19.39 mM)
-
SMILESCOC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
-
Chemical Name6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Brogden RN, et al. Drugs, 1997, 53(3), 511-519.
molnova catalog
related products
-
Ch55
Ch55 is an effective inducer of the differentiation of HL60 cells (EC50 = 200 nM) and shows high affinity with RAR-α and RAR-β receptors.
-
Sodium sulfadiazine
Sodium Sulfadiazine is a sodium salt form of sulfadiazine, an intermediate-acting bacteriostatic, synthetic sulfanilamide derivative.
-
BMS493
BMS493 is an inverse agonist of the pan-retinoic acid receptor (RAR) that inhibits retinoic acid-induced differentiation, enhances the interaction of nuclear co-inhibitors with RARs, attenuates RA signaling, potentiates TPP-induced toxicity, and inhibits the increase in phospholipase A2 activity.
Cart
sales@molnova.com